Suppr超能文献

安神定志方治疗 PTSD 小鼠的作用及机制: 从海马突触功能探讨。

Anshen Dingzhi prescription in the treatment of PTSD in mice: Investigation of the underlying mechanism from the perspective of hippocampal synaptic function.

机构信息

Key Laboratory of Xin'an Medicine, the Ministry of Education and Key Laboratory of Molecular Biology (Brain diseases), Anhui University of Chinese Medicine, Hefei, Anhui, 230038, China.

Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Hangzhou, Zhejiang, 310053, China.

出版信息

Phytomedicine. 2022 Jul;101:154139. doi: 10.1016/j.phymed.2022.154139. Epub 2022 Apr 30.

Abstract

BACKGROUND

Anshen Dingzhi prescription (ADP) is an important prescription for the treatment of mental diseases in traditional Chinese medicine and is widely used to treat neuropsychiatric disorders.

PURPOSE

To explore the ameliorative effect of ADP on post-traumatic stress disorder (PTSD)-like behaviors in mice and determine the underlying mechanism.

METHODS

The constituents of ADP were analyzed by UPLC-Q-TOF/MS. The PTSD-like behaviors of mice subjected to single prolonged stress (SPS) were evaluated using behavioral tests. Potential pathological changes in the hippocampus were assessed by hematoxylin and eosin (H&E) staining. Western blotting and immunohistochemistry (IHC) were employed to detect the expression of proteins involved in relevant signaling pathways.

RESULTS

Five quality control markers (ginsenoside Rg1, ginsenoside Rb1, tenuifolin, poricoic acid B, and α-asarone) were detected in the ADP solution. The ginsenoside Rg1 content in ADP was found to be 0.114 mg/g. Mice subjected to SPS showed obvious fear generalization and anxiety-like behaviors. ADP treatment prevented the behavioral changes caused by exposure to SPS. Compared with control animals, the number of normal pyramidal cells in the hippocampal CA1 region of mice exposed to SPS was decreased and the number of degenerating pyramidal cells was increased; however, ADP administration could counteract these effects. Furthermore, the protein expression of BDNF, p-TrkB, μ-calpain, PSD95, GluN2A, GluA1, p-AKT, p-mTOR, and ARC was decreased, while that of PTEN and GluN2B was increased in the hippocampus of mice subjected to SPS compared with that in control animals; however, these changes in protein expression were reversed following ADP treatment. Importantly, the ameliorative effect of ADP on PTSD-like behaviors and synaptic protein expression were inhibited by rapamycin administration.

CONCLUSIONS

ADP administration improves PTSD-like behaviors in mice and this effect may be mediated through an mTOR-dependent improvement in synaptic function in the hippocampus.

摘要

背景

安神定志方(ADP)是中医治疗精神疾病的重要方剂,广泛用于治疗神经精神疾病。

目的

探讨 ADP 对小鼠创伤后应激障碍(PTSD)样行为的改善作用及其作用机制。

方法

采用 UPLC-Q-TOF/MS 分析 ADP 的成分。采用行为学测试评估单次延长应激(SPS)后小鼠的 PTSD 样行为。通过苏木精和伊红(H&E)染色评估海马潜在的病理变化。采用 Western blot 和免疫组化(IHC)检测相关信号通路蛋白的表达。

结果

在 ADP 溶液中检测到 5 个质量控制标志物(人参皂苷 Rg1、人参皂苷 Rb1、金雀花碱、多孔菌酸 B 和 α-细辛脑)。ADP 中人参皂苷 Rg1 的含量为 0.114mg/g。SPS 处理的小鼠表现出明显的恐惧泛化和焦虑样行为。ADP 治疗可预防 SPS 暴露引起的行为改变。与对照组动物相比,SPS 暴露小鼠海马 CA1 区正常锥体神经元数量减少,退化锥体神经元数量增加;然而,ADP 给药可逆转这些效应。此外,与对照组相比,SPS 处理小鼠海马中 BDNF、p-TrkB、μ-钙蛋白酶、PSD95、GluN2A、GluA1、p-AKT、p-mTOR 和 ARC 的蛋白表达降低,PTEN 和 GluN2B 的蛋白表达增加;然而,ADP 处理后这些蛋白表达的变化得到逆转。重要的是,雷帕霉素给药抑制了 ADP 对 PTSD 样行为和突触蛋白表达的改善作用。

结论

ADP 给药可改善小鼠 PTSD 样行为,其作用可能是通过 mTOR 依赖性改善海马突触功能介导的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验